SCHEMBL10348598

SCHEMBL10348598

CCN(CC)c1ccc2sc(S(N)(=O)=O)nc2c1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA2 P00918 19/20 0.57
CA1 P00915 6/20 0.51
CA4 P22748 4/20 0.51
CA12 O43570 3/20 0.51
CA14 Q9ULX7 3/20 0.51
CA7 P43166 2/20 0.51
CA6 P23280 2/20 0.50
CA5A P35218 2/20 0.50
CA9 Q16790 2/20 0.50
CA5B Q9Y2D0 2/20 0.50
KDM4E B2RXH2 1/20 0.50
LMNA P02545 1/20 0.50
CA3 P07451 1/20 0.50
PKM P14618 1/20 0.50
KMT2A Q03164 1/20 0.50
HIF1A Q16665 1/20 0.50
CA13 Q8N1Q1 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
TERT O14746 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10348099 0.89 CA2 (0.60) CA2CA1CA4CA12CA14
SCHEMBL10348628 0.88 CA2 (0.49) CA2CA1CA4CA12CA14
SCHEMBL10347747 0.86 CA2 (0.58) CA2CA1CA4CA12CA14
SCHEMBL10348109 0.84 CA2 (0.52) CA2CA1CA4CA12CA14
SCHEMBL13480972 0.78 CA2 (0.58) CA2CA1CA4CA12CA14
SCHEMBL10348595 0.78 CA2 (0.56) CA2CA1CA4CA12CA14
SCHEMBL20140819 0.76 TERT (0.56) KDM4ELMNAPKMKMT2ATERT
SCHEMBL14317794 0.76 CA2 (0.67) CA2CA1CA4CA12CA14
SCHEMBL10348738 0.76 CA2 (0.58) CA2CA1CA4CA12CA14
SCHEMBL11115448 0.76 CA2 (0.55) CA2CA1CA4CA12CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0122831-B1 BENZOTHIAZOLE-2-SULFONAMIDE DERIVATIVES FOR THE TOPICAL TREATMENT OF ELEVATED INTRAOCULAR PRESSURE MERCK & CO. INC. (US) 1990-04-18 EP disclosed
US-4499103-A Benzothiazole-2-sulfonamide derivatives for the topical treatment of elevated intraocular pressure MERCK & CO., INC. (US) 1985-02-12 US disclosed
EP-0122831-A2 Benzothiazole-2-sulfonamide derivatives for the topical treatment of elevated intraocular pressure MERCK & CO. INC. (US) 1984-10-24 EP disclosed